Charles D. Goodwin II - Jan 10, 2024 Form 4 Insider Report for Apyx Medical Corp (APYX)

Role
Chief Executive Officer, Director
Signature
/s/ Charles D. Goodwin, II
Stock symbol
APYX
Transactions as of
Jan 10, 2024
Transactions value $
$0
Form type
4
Date filed
1/11/2024, 04:05 PM
Previous filing
Nov 15, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APYX Stock Option (Option to Buy) Award $0 +243K $0.00* 0 Jan 10, 2024 Common Stock 243K $2.42 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant.